Paclitaxel is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Paclitaxel.
| Product ID | 45963-613_2e201132-4f34-44e5-98a0-48fa8d952aa1 |
| NDC | 45963-613 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Paclitaxel |
| Generic Name | Paclitaxel |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2018-07-19 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA090130 |
| Labeler Name | Actavis Pharma, Inc. |
| Substance Name | PACLITAXEL |
| Active Ingredient Strength | 6 mg/mL |
| Pharm Classes | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2018-07-19 |
| Marketing End Date | 2022-07-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA090130 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2018-06-13 |
| Marketing End Date | 2021-08-31 |
| Marketing Category | ANDA |
| Application Number | ANDA090130 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2018-06-13 |
| Marketing Category | ANDA |
| Application Number | ANDA090130 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2018-06-13 |
| Marketing End Date | 2021-04-30 |
| Marketing Category | ANDA |
| Application Number | ANDA090130 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2018-07-19 |
| Marketing End Date | 2022-06-30 |
| Marketing Category | ANDA |
| Application Number | ANDA090130 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2018-07-19 |
| Marketing Category | ANDA |
| Application Number | ANDA090130 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2018-07-19 |
| Marketing End Date | 2022-07-31 |
| Ingredient | Strength |
|---|---|
| PACLITAXEL | 6 mg/mL |
| SPL SET ID: | 6cefbdb9-1141-4a53-9d05-f6fcc2746834 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0703-3213 | Paclitaxel | Paclitaxel |
| 0703-3216 | Paclitaxel | Paclitaxel |
| 0703-3217 | Paclitaxel | Paclitaxel |
| 0703-3218 | Paclitaxel | Paclitaxel |
| 0703-4764 | Paclitaxel | Paclitaxel |
| 0703-4766 | Paclitaxel | Paclitaxel |
| 0703-4767 | Paclitaxel | Paclitaxel |
| 0703-4768 | Paclitaxel | Paclitaxel |
| 16714-137 | Paclitaxel | Paclitaxel |
| 16729-098 | Paclitaxel | PACLITAXEL |
| 44567-504 | Paclitaxel | Paclitaxel |
| 44567-505 | Paclitaxel | Paclitaxel |
| 44567-506 | Paclitaxel | Paclitaxel |
| 45963-613 | Paclitaxel | Paclitaxel |
| 47781-593 | Paclitaxel | paclitaxel |
| 70860-200 | Paclitaxel | Paclitaxel |
| 47781-595 | Paclitaxel | Paclitaxel |
| 47781-594 | Paclitaxel | Paclitaxel |
| 51991-938 | Paclitaxel | Paclitaxel |
| 51991-937 | Paclitaxel | Paclitaxel |
| 51991-936 | Paclitaxel | Paclitaxel |
| 61703-342 | Paclitaxel | Paclitaxel |
| 63323-763 | Paclitaxel | Paclitaxel |
| 67457-449 | Paclitaxel | Paclitaxel |
| 67457-434 | Paclitaxel | Paclitaxel |
| 67457-471 | Paclitaxel | Paclitaxel |
| 70860-215 | Paclitaxel | Paclitaxel |
| 24979-710 | Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound) | Paclitaxel |